Vir Biotechnology Inc Environmental Analytics
Environmental and financial analysis dashboard for Vir Biotechnology Inc. Industry: PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES
Company Overview for Vir Biotechnology Inc
Highlights
Showing data for FY2022
Operational Environmental Cost
$18m
Operational Environmental Cost Intensity
1.11%
Total Environmental Cost
N/A
Total Environmental Cost Intensity
N/A
ΔOperational Environmental Cost (2020-2022)
$18m
Decoupling Rate (2020-2022)
-63%
Adjusted EBITDA
$841m
Adjusted EBITDA Margin
52%
Environmental cost statement
Showing data for FY2022
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| OPERATIONAL SOCIAL COST OF CARBON | ||||
| 1616.58% | 47.85% | -95.30% | ||
| 0.15% | 0.17% | 0.17% | 0.15% | |
| 2932.54% | 141.32% | -95.12% | ||
| 0.27% | 0.57% | 0.93% | 0.85% | |
| $0m | $8m | $18m | $1m | |
| 2471.59% | 119.47% | -95.15% | ||
| 0.42% | 0.75% | 1.11% | 1.01% | |
| INDIRECT SOCIAL COST OF CARBON | ||||
| N/A | N/A | N/A | ||
| N/A | N/A | N/A | N/A | |
| N/A | N/A | N/A | ||
| N/A | N/A | N/A | N/A | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. Scope 2: Social Cost of Carbon is calculated using market-based emissions data. | ||||
Environmental cost bridge
Showing data for FY2022
Integrated financial analysis
Highlights
Showing data for FY2022
Adjusted EBITDA Margin
52%
Adjusted EBIT Margin
52%
EV / Adjusted EBITDA
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
EV / Adjusted EBIT
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
Integrated income statement
Showing data for FY2022
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| INCOME STATEMENT | ||||
$76m | $1,095m | $1,616m | $86m | |
| 1334.36% | 47.51% | -94.67% | ||
$407m | $666m | $757m | $1,537m | |
| 533.55% | 60.76% | 46.86% | 1783.43% | |
$-331m | $430m | $859m | $-1,451m | |
| -433.55% | 39.24% | 53.14% | -1683.43% | |
$-337m | $424m | $852m | $-1,493m | |
| -441.64% | 38.71% | 52.71% | -1732.68% | |
| ENVIRONMENTAL COST DATA | ||||
$0m | $8m | $18m | $1m | |
| 0.42% | 0.75% | 1.11% | 1.01% | |
| FINANCIAL DATA ADJUSTED FOR OPERATIONAL ENVIRONMENTAL COST | ||||
$-331m | $422m | $841m | $-1,452m | |
| -433.96% | 38.49% | 52.03% | -1684.44% | |
$-338m | $416m | $834m | $-1,494m | |
| -442.05% | 37.96% | 51.60% | -1733.69% | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. | ||||
Environmental EBITDA bridge
Showing data for FY2022
Industry benchmark
RESEARCH AND EXPERIMENTAL DEVELOPMENT ON NATURAL SCIENCES AND ENGINEERING
Scope 1 (% of Sales)
0.17%
Scope 2 (% of Sales)
0.93%
Operational Environmental Cost Intensity
1.11%
Scope 3 (% of Sales)
N/A
Total Environmental Cost Intensity
N/A
Selected peer group
Showing data for FY2022
NAME | COUNTRY | OPERATIONAL ENV. COST | OPERATIONAL ENV. COST INTENSITY |
|---|---|---|---|
Vir Biotechnology Inc | US | $18m | 1.11% |
Loading similar companies data...
Industry distribution
Showing data for FY2022
Note: Outliers are calculated using the 1.5 * IQR method, where values outside Q1 - 1.5 * IQR and Q3 + 1.5 * IQR are considered outliers.
Estimated Social Cost of Carbon Scope 3 breakdown
Percentage breakdown of Social Cost of Carbon Scope 3 into various categories
Showing data for FY2022
SCOPE 3 CATEGORY | Company (USD) | Company % | Industry Avg (USD) | Industry Avg % |
|---|---|---|---|---|
Purchased goods (1 & 2) | N/A | N/A | N/A | N/A |
Energy-related activities (3) | N/A | N/A | N/A | N/A |
Upstream transportation (4) | N/A | N/A | N/A | N/A |
Waste (5) | N/A | N/A | N/A | N/A |
Business travel (6) | N/A | N/A | N/A | N/A |
Commuting (7) | N/A | N/A | N/A | N/A |
Upstream leased assets (8) | N/A | N/A | N/A | N/A |
Downstream transportation (9) | N/A | N/A | N/A | N/A |
Processing of products (10) | N/A | N/A | N/A | N/A |
Use of products (11) | N/A | N/A | N/A | N/A |
Final treatment of products (12) | N/A | N/A | N/A | N/A |
Downstream leased assets (13) | N/A | N/A | N/A | N/A |
Franchises (14) | N/A | N/A | N/A | N/A |
Investments (15) | N/A | N/A | N/A | N/A |
Total | $0m | 100.00% | $0m | 100.00% |
Scope 3 breakdown visualization
Showing data for FY2022